This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (134)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Genetic Counseling/ Testing/ Therapy  • Genetic Disorders  • Alert me on articles by topic

Analyses in Women Before Age 35 Years and in Women Before Age 45 Years With First-Degree Family History

Kathleen E. Malone, PhD; Janet R. Daling, PhD; Jennifer D. Thompson; Cecilia A. O'Brien; Leigh V. Francisco; Elaine A. Ostrander, PhD

JAMA. 1998;279:922-929.

Context.— Studies of high-risk families with multiple early-onset cases of breast cancer have been useful for assessing the type and spectrum of germline mutations on the BRCA1 gene, but do not provide guidance to women with modest family history profiles. Thus, studies of women from the general population are needed to determine the BRCA1 mutation frequency in women perceived to be at high risk, and to develop profiles of those most likely to be carriers.

Objective.— To characterize frequency and spectrum of germline BRCA1 mutations in 2 categories of women identified via population-based studies hypothesized to be at increased risk of carrying such mutations: those diagnosed as having breast cancer before age 35 years and those diagnosed before age 45 years who have first-degree breast cancer family history.

Design.— Study subjects were drawn from 2 population-based case-control studies of breast cancer in young women on the basis of their family history or their age of diagnosis. Cases were younger than 35 years or were younger than 45 years with first-degree family history at the time of breast cancer diagnosis and were ascertained via a population-based cancer registry, and controls (women without breast cancer) were identified via random-digit dialing.

Setting.— Three counties in western Washington State.

Main Outcome Measure.— BRCA1 germline mutations in study subjects identified in DNA from peripheral blood lymphocytes by single-strand conformation polymorphism analysis using primer pairs that span the BRCA1 coding region and intron-exon boundaries.

Results.— Of 193 women diagnosed as having breast cancer before age 35 years, none of whom were selected on the basis of family history status, 12 (6.2%, 95% confidence interval [CI], 3.2%-10.6%) had germline BRCA1 mutations. In 208 women diagnosed before age 45 years who had first-degree breast cancer family history, 15 (7.2%, 95% CI, 4.1%-11.6%) had germline mutations in BRCA1. In both groups, there were variations in mutation frequency noted by age and by family history. Mutation frequency decreased with increasing age of diagnosis. Higher proportions of mutations were seen in cases with at least 1 relative diagnosed as having breast cancer before age 45 years, in cases with greater numbers of affected relatives, and those with ovarian cancer family history. Mutation frequency did not vary by bilateral breast cancer family history. No frameshift or nonsense mutations were observed in 71 control women with a first-degree family history, although missense changes of unknown significance were seen in cases and controls.

Conclusions.— Women with BRCA1 germline mutations lacked a common family history profile. Also, a large proportion of the women with a first-degree breast cancer family history and women diagnosed as having breast cancer before age 35 years did not carry germline BRCA1 mutations. Hence, while early-onset disease and a strong breast cancer family history may be useful guidelines for checking BRCA1 status, these findings on women drawn from the general population suggest that it may be difficult to develop BRCA1 mutation screening criteria among women with modest family history profiles.

From the Public Health Sciences Division (Drs Malone and Daling and Ms O'Brien) and Clinical Research Division (Mss Thompson and Francisco and Dr Ostrander), Fred Hutchinson Cancer Research Center, Seattle, Wash.

RELATED ARTICLES

Frequency of Breast Cancer Attributable to BRCA1 in a Population-Based Series of American Women
Beth Newman, Hua Mu, Lesley M. Butler, Robert C. Millikan, Patricia G. Moorman, and Mary-Claire King
JAMA. 1998;279(12):915-921.
ABSTRACT | FULL TEXT  

BRCA1 Testing—Advances and Retreats
Fergus J. Couch and Lynn C. Hartmann
JAMA. 1998;279(12):955-957.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
Anders et al.
JCO 2008;26:3324-3330.
ABSTRACT | FULL TEXT  

Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups
John et al.
JAMA 2007;298:2869-2876.
ABSTRACT | FULL TEXT  

Validity of Models for Predicting BRCA1 and BRCA2 Mutations
Parmigiani et al.
ANN INTERN MED 2007;147:441-450.
ABSTRACT | FULL TEXT  

Marketing Genetic Tests: Empowerment or Snake Oil?
Bowen et al.
Health Educ Behav 2005;32:676-685.
ABSTRACT  

Prevalence of BRCA1 and BRCA2 Mutations in Women Diagnosed With Ductal Carcinoma In Situ
Claus et al.
JAMA 2005;293:964-969.
ABSTRACT | FULL TEXT  

Prevalence of BRCA1 Mutation Carriers among U.S. Non-Hispanic Whites
Whittemore et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:2078-2083.
ABSTRACT | FULL TEXT  

BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients
Rogozinska-Szczepka et al.
Ann Oncol 2004;15:1373-1376.
ABSTRACT | FULL TEXT  

Racial Meanings and Scientific Methods: Changing Policies for NIH-Sponsored Publications Reporting Human Variation
Stevens
Journal of Health Politics, Policy and Law 2003;28:1033-1088.
ABSTRACT  

The Use of Gene Tests to Detect Hereditary Predisposition to Chronic Disease: Is Cost-Effectiveness Analysis Relevant?
Col
Med Decis Making 2003;23:441-448.
ABSTRACT  

Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies
Ozcelik et al.
J. Med. Genet. 2003;40:e91-91.
FULL TEXT  

The Prognostic Impact of Hormone Receptors and c-erbB-2 in Pregnancy-Associated Breast Cancer and Their Correlation with BRCAI and Cell Cycle Modulators
Reed et al.
INT J SURG PATHOL 2003;11:65-74.
ABSTRACT  

Androgen Receptor (CAG)n and (GGC)n Polymorphisms and Breast Cancer Risk in a Population-Based Case-Control Study of Young Women
Suter et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:127-135.
ABSTRACT | FULL TEXT  

Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
Frank et al.
JCO 2002;20:1480-1490.
ABSTRACT | FULL TEXT  

Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1
Eng et al.
J. Med. Genet. 2001;38:824-833.
ABSTRACT | FULL TEXT  

Family History of Breast and Ovarian Cancers and BRCA1 and BRCA2 Mutations in a Population-Based Series of Early-Onset Breast Cancer
Loman et al.
JNCI J Natl Cancer Inst 2001;93:1215-1223.
ABSTRACT | FULL TEXT  

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
Bergthorsson et al.
J. Med. Genet. 2001;38:361-368.
ABSTRACT | FULL TEXT  

Cost of Genetic Counseling and Testing for BRCA1 and BRCA2 Breast Cancer Susceptibility Mutations
Lawrence et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:475-481.
ABSTRACT | FULL TEXT  

Comparisons of Two Breast Cancer Risk Estimates in Women with a Family History of Breast Cancer
McTiernan et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:333-338.
ABSTRACT | FULL TEXT  

Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview
Blackshear
Toxicol Pathol 2001;29:105-116.
ABSTRACT  

Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician
Taylor
Postgrad. Med. J. 2001;77:11-15.
ABSTRACT | FULL TEXT  

Are BRCA1- and BRCA2-Associated Breast Cancers Different? Prognosis of BRCA1-Associated Breast Cancer
Robson
JCO 2000;18:113s-118.
ABSTRACT | FULL TEXT  

Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history
ELLIS et al.
J. Med. Genet. 2000;37:792-794.
FULL TEXT  

Ethical Issues in Genetic Testing of Children
Ross and Moon
Arch Pediatr Adolesc Med 2000;154:873-879.
FULL TEXT  

Why Are the Majority of Hereditary Cases of Early-Onset Breast Cancer Sporadic? A Simulation Study
Cui and Hopper
Cancer Epidemiol. Biomarkers Prev. 2000;9:805-812.
ABSTRACT | FULL TEXT  

Major Improvement in the Efficacy of BRCA1 Mutation Screening Using Morphoclinical Features of Breast Cancer
Lidereau et al.
Cancer Res. 2000;60:1206-1210.
ABSTRACT | FULL TEXT  

Integrated Designs for Gene Discovery and Characterization
Zhao et al.
J Natl Cancer Inst Monogr 1999;1999:71-80.
ABSTRACT | FULL TEXT  

A 40-Year-Old Woman With a Strong Family History of Breast Cancer
Garber
JAMA 1999;282:1953-1960.
FULL TEXT  

Genetic Polymorphisms and Risk of Breast Cancer
Coughlin and Piper
Cancer Epidemiol. Biomarkers Prev. 1999;8:1023-1032.
FULL TEXT  

More About: Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Eisinger et al.
JNCI J Natl Cancer Inst 1999;91:1421-1422.
FULL TEXT  

Novel hMLH1 and hMSH2 Germline Mutations in African Americans With Colorectal Cancer
Weber et al.
JAMA 1999;281:2316-2320.
ABSTRACT | FULL TEXT  

BRCA1 and BRCA2: a Small Part of the Puzzle
Burke et al.
JNCI J Natl Cancer Inst 1999;91:904-905.
FULL TEXT  

Hereditary Risk of Breast and Ovarian Carcinoma: The Role of the Oncologist
Frank
The Oncologist 1998;3:403-412.
ABSTRACT | FULL TEXT  

BRCA1 and Medullary Breast Cancer
Eisinger et al.
JAMA 1998;280:1227-1228.
FULL TEXT  

More on BRCA1 and Breast Cancer
JWatch Women's Health 1998;1998:4-4.
FULL TEXT  

Limitations of BRCA1 as Marker for Breast Cancer Risk
JWatch General 1998;1998:6-6.
FULL TEXT  

BRCA1 Testing--Advances and Retreats
Couch and Hartmann
JAMA 1998;279:955-957.
FULL TEXT